| Ytd | -61.77% | |
| 1y | -70.39% |
| Open | 1.59 | Prev Close | 1.63 | Low | 1.50 | High | 1.59 | Mkt Cap | 3.28M |
| Vol | 6.87K | Avg Vol | 99.31K | EPS | -1.49 | P/E | -1.09 | Forward P/E | N/A |
| Beta | 4.08 | Short Ratio | 2.21 | Inst. Own | 0.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.08 | 200-d Avg | 3.13 | 1yr Est | 0.00 |
Gainers Eos Energy Enterprises, Inc. - Right (NASDAQ:EOSER) stock increased by 74.7% to $0.05 durin
KUALA LUMPUR, Malaysia, May 29, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“Bi
KUALA LUMPUR, Malaysia, March 11, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) to
Enhanced board oversight aligns subsidiary with disciplined capital allocation and strategic evaluat
BioNexus Gene Lab (NASDAQ: BGLC - Get Free Report) and Beauty Health (NASDAQ: SKIN - Get Free Report
BioNexus Gene Lab Corp. (NASDAQ: BGLC - Get Free Report) was up 1.7% during trading on Friday. The s
KUALA LUMPUR, Malaysia, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“B
KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) ("B
SHERIDAN, Wyo., Dec. 02, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC” or the “Company”),
KUALA LUMPUR, Malaysia and SINGAPORE, Dec. 01, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BG
KUALA LUMPUR, Malaysia and SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BG
KUALA LUMPUR, Malaysia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“B
BioNexus Gene Lab (NASDAQ: BGLC - Get Free Report) and PACS Group (NYSE: PACS - Get Free Report) are
Collaboration Expected to Advance FS2 Topical Platform and Strengthen BGLC's Biotech Footprint in As
KUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”, Nasdaq: B
KUALA LUMPUR, Malaysia, April 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC), a
KUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“
KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a
KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a
KUALA LUMPUR, Malaysia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- MRNA Scientific Sdn.
KUALA LUMPUR, Malaysia, Sept. 14, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC, th
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the co